6-K
Ayr Wellness Inc. (AYRWF)
UNITEDSTATESSECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TORULE 13a-16 OR 15d-16UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2024.
Commission File Number: 333-253466
AyrWellness Inc.
(Exact Name of Registrant as Specified in Charter)
2601South Bayshore Drive, Suite 900, Miami, FL, 33133
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ¨ Form 40-F x
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| AYR WELLNESS INC. | ||
|---|---|---|
| (Registrant) | ||
| Date:<br> September 19, 2024 | By: | /s/ Brad Asher |
| Name: | Brad Asher | |
| Title: | Chief Financial Officer |
EXHIBIT INDEX
| 99.1 | News Release dated September 18, 2024 |
|---|
Exhibit 99.1
AYR WELLNESS ANNOUNCES CHANGES TO MANAGEMENT
Miami – September 18, 2024 – AYR Wellness Inc. (“AYR” or the “Company”) (CSE: AYR.A, OTCQX: AYRWF) a leading vertically integrated U.S. multi-state cannabis operator, today announced that, effective today, David Goubert has stepped down as the President and Chief Executive Officer of the Company. Mr. Goubert served as President of the Company from October 12, 2022 and as Chief Executive Officer of the Company from February 13, 2023. The Board of Directors of the Company (the “Board”) thanks Mr. Goubert for his dedication to AYR and wishes him the best in his future endeavours.
Appointment of Interim Chief Executive Officer
The Board has approved the appointment of Steven M. Cohen as Interim Chief Executive Officer of the Company, effective immediately. Mr. Cohen previously served as outside legal advisor to the Company. The Board will embark on a search for a permanent Chief Executive Officer in due course.
About AYR Wellness Inc.
AYR is a vertically integrated, U.S. multi-state cannabis business. The Company operates simultaneously as a retailer with 90+ licensed dispensaries and a house of cannabis CPG brands.
AYR is committed to delivering high-quality cannabis products to its patients and customers while acting as a Force for Good for its team members and the communities that the Company serves. For more information, please visit www.ayrwellness.com.
Company/Media Contact:
Robert Vanisko
VP, Public Engagement
T: (786) 885-0397
Email: [email protected]
Company Contact:
Jon DeCourcey
Head of Investor Relations
T: (786) 885-0397
Email: [email protected]
Investor Relations Contact:
Sean Mansouri, CFA
Elevate IR
T: (786) 885-0397
Email: [email protected]